Four New Sites Added to the MDV3100 ... - Advanced Prostate Cancer

The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced prostate cancer previously treated with Docetaxel based chemotherapy.

The new sites are located in Abington Pennsylvania, Santa Rosa California, Portland Oregon and Washington DC.

This trial will provide men with advanced prostate cancer who qualify access to MDV3100 prior to a final approval decision from the FDA. In this trial there will NOT be any placebo as well as no cost for the MDV3100/ enzalutamide (check with trial site for any other costs).
?
?
Basic Eligibility Criteria:

CRPC/HRPC ? on hormone therapy with progressive disease
Metastatic
3 weeks since taking Zytiga (abiraterone).
Previously treated with Taxotere (docetaxel)
No small cell or neuroendocrine features.
No brain metastases.
No history of stroke or seizure.
No significant cardiovascular disease.
HGB 9.0 or higher.

If you think you fit?this Basic Eligibility?Criteria, contact one of the sites below for further screening.

Alaska
Alaska Clinical Research Center, LLC
Contact: Robin Adams (907) 276-1455
Anchorage, Alaska 99508

Arizona
Pinnacle Oncology/Hematology
Contact: Sherril Bierman (480) 278-8804
Scottsdale, AZ 85258

California
Prostate Oncology Specialists
Contact: Jennifer Leung (310) 827-7707
Marina del Rey, CA 90292

Dr Ronald Yanagihara
Contact: Katrina or Lara (408) 847-6194
Gilroy, CA 95020
?
Tower Urology/ Tower Research Institute
Contact:? Maria Reyes (310) 854-9898? x160
Los Angeles, CA? 90048
?
Stanford University Cancer Ctr
Contact:? Denise Haas?(650) 736-1252
Palo Alto, CA? 94304

?
Redwood Regional Medical Group
Contact:? Jackie Malin (707) 521-3836
Santa Rosa, CA? 95403

Florida
Ocala Oncology Center
Contact:? Amy Liebman?(352) 732-4938
Ocala, FL? 34471

Georgia
PeachTree Hematology Oncology Consultants
Contact: Ann Johnston (678) 298-3241
Atlanta, GA
?
Northwest Georgia Oncology Centers
Contact:? Mary Gilley (770) 281-5131
Marietta, GA? 30060

Illinois
Illinois Cancer Care
Contact:?Lori Lynch? (309) 243-3627
Peoria, IL 61615

Indiana
Investigative Clinical Research of Indiana LLC
Contact: Leslie Weitman (317) 716-0323
Indianapolis, IN 46260
?
Louisiana
Metairie Oncologist
Contact:? Lucy Cousin? (504) 885-0577 x 317
Metairie, LA? 70006

Mississippi
Jackson Oncology Associates PLLC
Contact: Teresa Davis (601) 974-5547
Jackson, Mississippi 39202
?
Nebraska
Nebraska Hematology Oncology
Contact:? Ashley Waldred?(402) 484-4908
Lincoln, NE? 68506
?
Nevada
Comprehensive Cancer Centers of Nevada
Contact:? Ann Lovelace?(702) 952-3400?x 5414
Las Vegas, NV? 89169

New Hampshire
New Hampshire Oncology Hematology PA
Contact: Margaret White (603) 224-2556 x 1323
Hooksett, New Hampshire, 03106

New York
Accumed Research Associates
Contact: Tammi Allegra (516) 746-2190
Garden City, New York, 11530
?
Associated Medical Professionals of New York
Contact:? Tonya Godfrey? (315) 706-8112
Syracuse,?NY? 13210

North Carolina
Cancer Centers of North Carolina
Contact: Julia Berry (919) 781-7070
Raleigh, North Carolina 27607
?
Oklahoma
Tulsa Cancer Institute
Contact:? Sharon Franklin? (918) 292-8085
Tulsa, OK? 74136
?
Tulsa Southwestern Regional Med Ctr
Contact:? Jennifer Dvorak? (918) 286-5448
Tulsa, OK? 74133
?
Oregon
Oregon Urology Institute
Contact:?Stephanie Kerns? (541) 284-5508
Eugene, OR? 97477
?
Oregon Health & Science University
Contact:? Kristi Eilers? (503) 494-2897
Portland, OR? 97239

Pennsylvania
University of Pennsylvania
Contact:? Jenelle Robinson? (215) 662-7398
Philadelphia, PA? 19104
?
Abington Memorial Hospital
Contact:? Mabry Sondra? (215) 481-2402
Abington, PA? 19001
?
South Carolina
Charleston Hematology Oncology Associates, PA
Contact: Deborah McNeal (843) 266-2540
Charleston, South Carolina, 29414

Carolina Urologic Research Center
Contact: Tabitha Joyner (843) 449-1010 x228
Myrtle Beach, South Carolina, 29572

Tennessee
The Jones Clinic, PC
Contact:?Morgan Medus?(901) 685-5969 x322
Germantown, TN 38138
?
Texas
UT Southwestern Medical Ctr
Contact:? Allison Beaver? (214) 645-5921
Dallas, TX? 75390

Virginia
Virginia Oncology Associates
Contact: Wendi Gobhardt (757) 213-5813
Norfolk, VA, 23502
?
Washington
Northwest Medical Specialties
Contact:? Linda Dheane (253) 302-2896
Tacoma, WA? 98405
?
Washington DC
George Washington Univ
Contact:? Hiwot Guebre-Xabiher? (202) 741-2981
Washington DC, 20037
?
?
* Enrollment Tip ? ?It often takes a few weeks to complete the enrollment and screening process for an expanded access trial. You may be able to speed up this process
by supplying the clinical trial nurse with your own medical records, which may relieve him/her from trying to obtain them from another clinic. Factor all of this into your decisions. As always, discuss with your physician(s) the pros and cons of your participating in this or any other clinical trial.

Joel T. Nowak, M.A, M.S.W.
?

Source: http://advancedprostatecancer.net/?p=3399

last house on the left last house on the left rich forever mixtape blow the unit bob weston bill obrien